Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Hospital Statistics 2015-16

Publication

Publications

Textbook of Radiation Oncology: Principles and Practice. G.K. Rath and B.K. Mohanti (eds). New Delhi: BI Churchill Livingstone, 2000 (ISBN 81-7042-166-7); Elsevier, 2003 (Reprint)
  1. Awasthy BS, Julka PK, Rath GK. Medulloblastoma – A retrospective analysis. Ind J Pediat 1998.

  2. Awasthy BS, Julka PK, Aggarwal S, Nair O, Bhamrah R, Rath GK. Effect of amifostine on toxicities associated with salvage combination chemotherapy. J Assoc Physicians India. 2001: 49;236-9

  3. Bansal M, Mohanti BK. Sentinel lymph node biopsy, axillary dissection and breast cancer Radiation Oncologist’s viewpoint. Natl Med J India. 2002; 15: 154-57.

  4. Bharanidharan G, Durai K, Subramani V, Gopishankar N, Ganesh T etal. characterization of responses and comparison of calibration factors for commercial MOSFEt detectors. Med Dosim 2005;30:213.

  5. Biswal BM, Mohanti BK, Rath GK, Kumar L, Kriplani A, Ganesh T, Takkar D, Kumar S. Results of radical radiotherapy in carcinoma of the uterine cervix stage I-III. Clin. Oncol. 1994; 6:356-360.

  6. Biswal BM, Lal P, Rath GK, Shukla NK, Mohanti BK, Deo SVS. Intrarectal formalin application, an effective treatment for grade III haemorrhagic radiation proctitis. Radiother. Oncol. 1995; 35:212-215

  7. Chander S, Datta NR, Singh K, and Rath GK. Evaluation of electron beam irradiation technique in Indian breast carcinoma patients. Ind J Med Sci 1990;44:143-147.

  8. Chander S, Gupta MR, Rath GK et al. Low dose rate transperineal template Brachytherapy in for carcinoma cervix. J Brachyther Int 1999; 15 (3):

  9. D’Souza H, Joshi RC, Ganesh T, Subramani V, Vasu G, Kumar R, Julka PK and Rath GK Variation in the isocentre of a Philips Linear Accelerator (SL-20) used for stereotactic radiosurgery/ stereotactic radiotherapy. Australian Radiology. 1999; 43(3), 342-345.

  10. Ganesh T, Sharma S, Joshi RC, Singhal S, Shahi UP, Kumar R, Rath GK. Calculation of Reference Volume from Total Reference Air Kerma:A simple procedure. J Int Fed Med Biol Eng 1991;29 supp 2 :1229

  11. Majhail N S, Chander S, Mehta V S, Julka P K, Gansesh T, Rath G K. Factors influencing early complications following gama knife radiosurgery. Stereotact funet Neurosurg. 2001;76:36.

  12. Julka PK, Awasthy BS, Rath GK, Aggarwal S, Varna T, Mahapatra AK, Singh R. Study of concurrent radiochemotherapy with Paclitaxel in Glioblastoma Multiforme. Australasian Radiology. 2000; 44, 84-87.

  13. Julka PK, Sharma DN, Mukhopadhyay P, Rath GK. Trastuzumab and docetaxel in metastatic breast cancer. Clin Oncol. 2004; 16:115-118.

  14. Mohanti BK, Shukla NK, Chawla S, Ganesh T et al. Experience with intraluminal radiotherapy in advanced oesophageal cancer. Trop. Gastroenterol. 1995; 16:27-32.

  15. Mohanti BK, Tandon DA, Bahadur S, Rath GK, Tanwar RK, Lal P and Biswal BM. Results of definitive radiotherapy in T1 and T2 glottic carcinoma : Institute of Rotary Cancer Hospital experience. Australasian Radiol. 1996; 40;287-290.

  16. Mohanti BK, Rath GK, Anantha N, Kannan V et al. Improving cancer radiotherapy with 2-deoxy-d-glucose: Phase I/II clinical trials on human cerebral gliomas. Int. J. Radiat Oncol. Biol. Phys. 1996; 35:103-111.

  17. Mohanti BK, Swami K, Ganesh T, Lal P, Biswal BM, Joshi RC, D’Souza H and Rath GK. Iridium-192 interstitial brachytherapy in carcinoma of the tongue. Acta Oncol. 1997; 36:165-169.

  18. Mohanti B K, Nachiappan P, Pandey R M, Sharma et al. Analysis of 2167 head and neck cancer patients management, treatment compliance and outcomes from a regional cancer centre, Delhi, India. J. Laryngol otol:2006, 1-8.

  19. Mohanti B K, Bansal M. Review late sequelae of radiotherapy in adults. Support care cancer 2005;13:775-80.

  20. Mohanti BK. Radiotherapy in malignant gliomas. Editorial. The Cancer J. 1997; 10:3-4.

  21. Mohanti BK, Bansal M, Bahadur S, Shukla NK, Prabhakar R et al.. Interstitial brachytherapy with or without external beam irradiation in head and neck cancer: Institute Rotary Cancer Hospital experience. Clin Oncol. 2001;13: 345-52.

  22. Parida DK, Verma KK, Chander S, Joshi RC, Rath GK. Cutaneous T-Cell lymphoma treated with electron beam irradiation in Indian patients. Int J Dermatol 2001;40:295-297.

  23. Rath GK, Chander S, De S, Kumar R. Total Skin Electron irradiation for mycosis fungoides. Ind J Cancer 1986; 23: 146-50.

  24. Rath GK, Chander S, Grover R. Unveiling the multifarious developments in the treatment of cervical cancer for over a centenary. JIMA 1995;93(11):425-427.

  25. Rath GK, Deo SVS. Consensus on oral cancer management-AIIMS perspective. Asian Pac J Cancer Prev 2000;1:117-118

  26. Rath GK, Syed AMN, Gopi S et al. “INDIRA” Trial: De novo low dose rate intracoronary irradiation after angioplasty and stent placement for prevention of restenosis. J Brachyth Int 2001;17:317-330.

  27. Rath GK, Sharma DN, Julka PK. ICRU report 38: has the radiation oncology community accepted it? International Commission on Radiation Units & Measurements. Clin Oncol 2002;14(5):430-1

  28. Rath GK, Sharma DN. Newer techniques of radiation therapy in lung cancer. (Editorial) Ind J Chest Dis Allied Sci 2002: 155-7.
  29. Sharma DN, Chawla S, Gairola M, Mohanti BK, Deo SVS, Shukla NK, Rath GK. Biliary tract neoplasms. Trop. Gastroenterol. 1998; 19:56-58.

  30. Sharma DN. Gairola M, Mohanti BK, Rath GK. Radiation Therapy in skeletal metastasis. Med. J. Malaysia. 1999; 54: 210-215.

  31. Sharma DN, Chander S, Gairola M, Kumar S, Kumar L, Rath G K. Intravaginal Brachytherapy alone and in combination to external beam radiation therapy in the postoperative management of FIGO stage I-II endometrial carcinoma. J Brachyther Int 2000; 16: 173-180.

  32. Sharma S, Singhal S, De S, Chander S, Rath G K, Misra A and Khosla A. Primary Gastric Lymphoma: A Prospective Analysis of 12 cases and Review of the Literature. J Surg Oncol 1990; 43: 231-238.

  33. Sharma U., Robert S.M., Julka P.K. and Parameswaran T.: Primary Bone Lymphoma (1986). Ind. J.Cancer, 23:157-162.

  34. Singh RK, Parida DK, Mohanti BK, Rath GK. Preoperative Radiotherapy for squamous cell carcinoma of the esophagus. Int J Surg Inv. 2001; 3:401-6.

  35. S Pathy, S Jayalakshmi, S Chander, R Singh, P K Julan, G K Rath Prognostic Factors influencing the outcome of thalmic glioma. Neurology India 50. March 2002;37-40

  36. B Mohanti, H Umapahty, S Bahadur, A, Thakar, S Pathy Short Course Palliative Radiotherapy of 20 gy in 5 fractions fro advanced and incurable head and neck cancer AIIMS study radiotherapy Oncol 71, (2004) 275-280.

Research

Research Projects

  1. Adjuvant Tamoxifen-Longer Against Shorter (ATLAS).

  2. A phase III study of Gemcitabine plus Paclitaxel versus Paclitaxel in patients with unresectable, locally recurrent or metastatic breast cancer. B0E-MC-JHQG.

  3. A phase 3 trial of Alimta Vs Docetaxel in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy.

  4. A randomized, controlled, open label study to evaluate the efficacy and safety of Herceptin® (trastuzumab) in combination with the oral aromatase inhibitor Arimidex® (anastrozole) compared with Arimidex® alone as first and second line treatment administered to postmenopausal, hormone receptor positive (ER+ve and/or PR+ve) patients with HER2 overexpressing metastatic breast cancer.

  5. Multicenter Phase III randomized trial comparing doxorubicin and Cyclophosphamide followed by Docetaxel (AC--t) with Doxorubicin and Cyclophosphamide followed by Docetaxel and Trastuzumab (Erceptin) (AC--TH) and with Docetaxel, Carboplatin and Trastuzumab (TCH) in the Adjuvant treatment of node positive and high risk node negative patients with operable Breast cancer containing the HER2 alteration.

  6. A centrally randomized, open multi-center study evaluating the efficacy and safety of combination therapy with Intermax alphaTM and vinblastine versus vinblastine monothreapy in patients with Advanced Cell Carcinoma

  7. A Phase 2 study of Sequential Neoadjuvant Gemcitabine Plus Doxorubicin and Gemcitabine Plus Cisplatin in Large T2 ( 3cm) and Locally Advanced (T3 T4 or N2) Operable Breast Cancer"

  8. A Randomized, double blind, placebo control, phase II study of oral recombinant human lactoferrin (rhLF) in combination with carboplatin and paclitaxel (C/P) chemotherapy in patients with locally advanced and/or metastatic non-small-cell lung cancer (NSCLC)

  9. International Multicenter Trial funded by IAEA, Vienna titled “ A randomized study of 5 versus 6 weekly fractions of radiotherapy in the treatment of squamous cell carcinoma of the Head and Neck – Aspects of radiobiology applicable in clinical radiotherapy – increase of the number of fractions per week. IAEA-CRP.E.3.30.18

  10. Concurrent chemo-radiotherapy for oropharyngeal and hypopharyngeal cancers.

  11. Concurrent chemo-radiotherapy as postoperative adjuvant therapy in operable stomach and hepatobiliary neoplasms.

Inpatient

InPatient Services

RT ward : 32 beds

Patient Education

Patient Education

Patients and their relatives are educated through pamphlets, frequent interactions etc. regarding the status of their disease, intended treatment, care and precautions to be taken during treatment and expected outcome.  

Outpatient

Outpatient Services

Name of the OPDDay & TimeSpecial Instruction
Radiotherapy Evaluation Tuesday & Friday 9 A.M Patients are generally seen On referral with confirmed Histopathology

आलेख और अधिक ...

  1. Staff
  2. Faculty
  3. Dr. Sushmita Pathy
  4. Dr. Suman Bhaskar
Top of Page